摘要
目的 评估静脉滴注拉贝洛尔治疗老年高血压急症的临床疗效及安全性分析。方法 本文以64位老年高血压急症患者为研究对象，给予静脉滴注拉贝洛尔（1-4mg／min）降压治疗。结果 治疗前血压为（205．69±25．42）／（111．24±15．91）mmHg。拉贝洛尔治疗2h后81．3％（50／64）患者平均血压下降15％～25％，治疗6h后血压控制在21．3／13．3kPa以下者为94％，拉贝洛尔降压起效快且无低血压现象发生。结论 静脉滴注拉贝洛尔治疗老年高血压急症有效、安全。
Objective To evaluate the efficacy and safety of intravenous drip labetalot in treatment of elder hypertension emergencies. Method The study was conducted in 64 elder patients with hypertension emergencies who were received intravenous labetalol（1 -4mg/min）. Results Pretreatment blood pressure were 205.69±25.42/111.24 ±15.91mmHg. Treatment response （15 % -25 % decrease in mean arterial pressure） was achieved in 81.3 % （50/64） of labetalol - treated patients. After 6h treatment, 94 % patients reached goal blood pressure （〈 21.3/13.3 kPa） within short response time and no hypotention was observed in labetalol- treated patients. Conclusion These results suggest that intravenous drip of labetalol is highly effective and safe in treatment of elder hypertension emergencies.
出处
《实用预防医学》
CAS
2007年第1期159-161,共3页
Practical Preventive Medicine
关键词
高血压急症
拉贝洛尔
疗效
Hypertension emergencies
Labetalol
Efficacy
